×

To enhance security, Multi-Factor Authentication (MFA) is mandatory for all HL7 users. More information

 

FHIR Representation of Eligibility Criteria for Clinical Trials (Jira PSS-2127)

Basics

FHIR Representation of Eligibility Criteria for Clinical Trials (Jira PSS-2127)

1799
Ballot - STU


FHIR Implementation Guide; FHIR Profile

Create New Standard, Implementation Guide

Details

This project will develop implementation guidance to support FHIR representation of Eligibility Criteria for Clinical Trials.

The BR&R WG has been working on this use case for several months and has done extensive work discussed during weekly BR&R calls. EBM on FHIR project has also been involved in these discussions. The work-in-progress is here on BR&R WG confluence pages – https://confluence.hl7.org/pages/viewpage.action?pageId=81013279

Examples of FHIR representation of eligibility criteria can be found at https://fevir.net/resources/Project/32444


In clinical trials a study’s protocol has instructions or rules on who can or cannot participate in the study. These instructions, called eligibility criteria, describe characteristics that must be shared by all study participants. The criteria differ from study to study. Eligibility criteria include both inclusion and exclusion criteria and may be comprised of age, gender, medical history, and current health status, severity of the disease being studied, and concomitant medications. Eligibility criteria for treatment studies often require that patients have a particular indication, type of disease and stage of disease.

There are many efforts to structure eligibility criteria for clinical trials, but none that have represented it in FHIR adequately to meet the business need. The structuring of eligibility criteria in FHIR will support several data exchange scenarios: a clinical trials registry that includes submission of eligibility criteria; supporting trial matching services; supporting the data exchange between hospital information systems and clinical trials management systems as well as trial planning efforts (including estimation of potential sample size at study sites).



FHIR IG R1 STU Ballot: Target Sept 2023 Ballot Cycle FHIR Profile: R1 STU Ballot: Target Sept 2023 Ballot Cycle


https://confluence.hl7.org/pages/viewpage.action?pageId=81013279 PSS: https://jira.hl7.org/browse/PSS-2127

None

Dependency on EvidenceVariable Resource work being done in CDS WG.

Other (specify in Misc. Notes below),N/A

Computable Publishing LLC; German Medical Informatics Initiative; European Vaccines Network

EMA Direct Data Capture (DDC) Initiative; ICH M11: Clinical electronic Structured Harmonised Protocol (CeSHarP);

Structured Eligibility Criteria; Eligibility Criteria


N/A

N/A

No

Stakeholders: Academic/Research, Association/Goverment Agency, Consultant, Healthcare IT Vendors, Pharmaceutical/Biotech, Standards Development Organizations (SDOs), Vendor/Manufacturer
Organization & Realm

Universal

People

Brian Alper



Biomedical Research and Regulation Work Group

Clinical Decision Support Work Group; Clinical Interoperability Council Work Group; Clinical Quality Information Work Group

Status & Dates

Active

Active Project (Resources assigned to pjt)

10/27/2022

01/01/2024

2024 Jan WGM/Ballot

09/01/2023

2023 Sept WGM/Ballot

Approvals

11/22/2022


Not Needed


All Received




FHIR Management Group -- Agreed -- (PSS-2130)
System Info

201018

PSS-2127



02/02/2026

Jira Project Service